News Tilray 1.0 quietly discloses first-quarter US$341M loss In the final quarter before merging with Aphria, Tilray shows fiscal weakness Jared GnamMay 11, 2021
Analysis Writedowns and growing pains ahead for Tilray 2.0, analyst says But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market Jared GnamMay 3, 2021
Industry update Tilray reduces required shareholder vote count to 1/3 for Aphria merger The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30 Jared GnamApril 16, 2021
Industry update Tilray to supply medical pot in France, Aphria expands brand in Germany Soon-to-merge Canadian mega-producers expand international operations Jared GnamJanuary 26, 2021
Industry update Alcanna, YSS to target cannabis value segment with retail merger New company to be named Nova Cannabis, with most of its 53 stores in three provinces re-branded as Value Buds Jared GnamJanuary 18, 2021
Industry update Tilray and Aphria unveil merger plan to create world’s biggest weed firm But the $5B all-stock deal raised doubts if two bloated producers could combine to become anything better Jared GnamDecember 16, 2020